About Genefront Inc

Pioneering the future of Extracellular Vesicles therapeutics and diagnostics

Our Mission

To revolutionize healthcare through innovative Extracellular Vesicles technologies that enable precision medicine and improve patient outcomes worldwide.

We are committed to developing cutting-edge hiPSC-derived Extracellular Vesicles platforms that address unmet medical needs in regenerative medicine, drug delivery, and diagnostic applications. Our focus on quality, scalability, and regulatory compliance ensures that our technologies can make a meaningful impact on global health.

Our Vision

To be the global leader in Extracellular Vesicles-based therapeutics, enabling personalized medicine for patients across diverse disease areas.

We envision a future where Extracellular Vesicles technologies provide safe, effective, and accessible treatments for conditions ranging from cardiovascular disease to neurological disorders. Through continuous innovation and strategic partnerships, we aim to transform the landscape of modern medicine.

Leadership Team

Experienced leaders driving innovation in biotechnology and healthcare

Microscope Icon

Sarvesh Adda, Ph.D

President

Fifteen plus years of experience as Managing director involved in Assay, IVD Kits development and Drug Discovery. Worked as Senior Scientist for big Pharma like Merck and Quality Assurance Specialist for J&J and Abott. Held Research Associate positions in Molecular Immunology at Stanford University, Scripps and Upenn.

Microscope Icon

Samarjit Das, Ph.D

Vice president, R&D

Assistant professor at Johns hopkins and 10+ years in EVs and bioprocessing, developed patented RNA-based diagnostics for heart disease, diabetes, and COVID-19.

Microscope Icon

Jacob Eapen MD, MPH

Director Medical Affairs

Dr. Jacob Eapen (Medical Director Rtd., Alameda Health System, California, USA; President, Washington Hospital Health System, Fremont, California) has over 45 years of experience in the medical field. His endless work has earned him local, state and national recognition and awards. His focus is to disseminate accurate, evidence-based information about a company's products and therapeutic areas to medical professionals and patients.

Microscope Icon

Sree Krishna, Ph.D

Director of Computational Biology and Bioinformatics

Director of Computational Biology with 16 years’ experience in Bioinformatics, ML, AI, and Deep Learning, developing biomedical applications and solutions.

Our Values

Guiding principles that drive our commitment to excellence

Innovation

Continuous pursuit of breakthrough technologies that push the boundaries of what's possible in Extracellular Vesicles therapeutics.

Quality

Uncompromising commitment to the highest standards of product quality, safety, and regulatory compliance.

Collaboration

Building strong partnerships with researchers, clinicians, and industry leaders to accelerate therapeutic development.